Clinical Trials Directory

Trials / Suspended

SuspendedNCT00668798

Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms

Incidence and Clinical Outcome of Human Cytomegalovirus Transmission Via Thawed Frozen Breast Milk in Preterm Infants <31 Weeks. A Prospective Trial.

Status
Suspended
Phase
Study type
Observational
Enrollment
58 (actual)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
24 Weeks – 31 Weeks
Healthy volunteers
Not accepted

Summary

Cytomegalovirus infection threatens preterm infant. We investigated, whether thawed breast milk is a mode of transmission

Detailed description

Preterm infants are at risk of symptomatic human cytomegalovirus infections transmitted by breast milk. This study evaluates incidence, timing, and clinical rlevance of acquired human CMV infections in preterm infants younger than 32 weeks of gestational age receiving maternal thawed frozen breast milk until 33 completed weeks of gestational age.

Conditions

Timeline

Start date
2005-01-01
Primary completion
2008-01-01
Completion
2008-03-01
First posted
2008-04-29
Last updated
2008-04-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00668798. Inclusion in this directory is not an endorsement.

Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms (NCT00668798) · Clinical Trials Directory